CRIMINAL LAWAND PROCEDURE
318
Bezitramide (9800)
Bulk dextropropoxyphene (nondosage forms)
(9273)
Carfentanil (9743)
Dihydrocodeine (9120)
Diphenoxylate (9170)
Fentanyl (9801)
Isomethadone (9226)
Levo-alphacetylmethadol (9648). Other
names: Levo-alpha-acetylmethadol; lev-
omethadyl acetate; and LAAM.
Levomethorphan (9210)
Levorphanol (9220)
Metazocine (9240)
Methadone (9250)
Methadone-Intermediate, 4-cyano-2-dimethyl-
amino-4, 4-diphenyl butane (9254)
Moramide-Intermediate, 2-methyl-3-mor
pholino-1, 1-diphenylpropane- carboxylic
acid (9802)
Pethidine (Meperidine) (9230)
Pethidine-Intermediate- A, 4-cyano-1-methyl-
4-phenylpiperidine (9232)
Pethidine-Intermediate-B,ethyl-4-phenyl-
piperidine-4-carboxylate (9233)
Pethidine-Intermediate-C,1-methyl-4-
phenylpiperidine-4-carbo xylic acid (9234)
Phenazodine (9715)
Piminodine (9730)
Racemethorphan (9732)
Racemorphan (9733)
Remifentanil (9739)
Sufentanil (9740)
Tapentadol
(d) Stimulants. Any material compound, mix-
ture, or preparation which contains any quantity
of the following substances having a potential
for abuse associated with a stimulant effect on the
central nervous system:
(1) Amphetamine, its salts, optical iso-
mers, and salts of its optical isomers
(1100).
(2) Methamphetamine, including its salts,
isomers, and salts of its isomers (1105).
(3) Phenmetrazine and its salts (1631).
(4) Methylphenidate (1724).
(5) Lisdexamfetamine, its salts, its iso-
mers, and salts of its isomers.
(e) Depressants. Unless specifically excepted
by rule of the board or unless listed in another
schedule, any material, compound, mixture, or
preparation which contains any quantity of the fol-
lowing substances having a depressant effect on
the central nervous system, including its salts,
isomers, and salts of isomers whenever the exis-
tence of such salts, isomers, and salts of isomers
is possible within the specific chemical designa-
tion:
Amobarbital (2125)
Glutethimide (2550)
Pentobarbital (2270)
Phencyclidine (7471)
Secobarbital (2315)
(f) Immediate precursors. Unless specifically
excepted by rule of the board or unless listed in
another schedule, any material, compound, mix-
ture, or preparation which contains any quantity
of the following substances:
(1) Immediate precursor to amphetamine
and methamphetamine: Phenylacetone
(8501). Some trade or other names: phenyl-
2-propanone; P2P; benzyl methyl ketone;
methyl benzyl ketone.
(2) Immediate precursors to phencyclidine
(PCP):
(A)1-phenylcyclohexylamine (7460);
or
(B)1-piperidinocyclohexanecarboni-
trile (PCC) (8603).
(3) Immediate precursor to fentanyl: 4-
Anilino-N-Phenethyl-4-Piperidine
(ANPP).
(g) Hallucinogenic substances: Nabilone
(7379). Other name: (+--)-trans-3- (1,1-dimethyl-
heptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy
-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
35-48-2-7. Schedule III tests.
(a) The board shall recommend placement of
a substance in schedule III under this chapter if it
finds that:
(1) The substance has a potential for abuse
less than the substances listed in schedule
I and II under this chapter;
(2) The substance has currently accepted
medical use in treatment in the United
States; and
(3) Abuse of the substance may lead to
